HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Platz, E. A. Search for Related Content PubMed PubMed Citation Articles by Platz, E. A. Related Collections Perspective

Low Testosterone and Risk of Premature Death in Older Men: Analytical and Preanalytical Issues in Measuring Circulating Testosterone

¹ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

Address correspondence to the author at: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St., Rm E6132, Baltimore, MD 21205. E-mail eplatz@jhsph.edu

The first 300 words of the full text of this article appear below.

Two recent papers in Circulation (1) and Journal of Clinical Endocrinology and Metabolism (2) reported that older men with lower serum testosterone concentrations had a greater risk of dying than did men with higher testosterone. This potentially clinically important finding was not observed in 2 other prospective cohort studies (3)(4), and another cohort study reported that low concentrations of a combination of hormones, but not of bioavailable testosterone alone, were associated with death (5). These studies raise important issues related to measuring testosterone for etiologic and clinical use.

motivation for discussing issues in measuring testosterone
An important question in clinical epidemiology is whether low testosterone concentrations are causally associated with premature death in older men. At least 3 scenarios (Fig. 1 ) may underlie the observation that older men with low testosterone are more likely to die (1)(2). Scenario 1: Disease states cause low testosterone, which in turn causes premature death, although disease states also may cause death via other mechanisms. In this scenario, either preventing disease states or intervening to increase low testosterone secondary to disease states could, in theory, reduce risk of death. Scenario 2: Disease states cause both premature death and low testosterone. If low testosterone does not cause death, it will nevertheless appear to be a risk factor for death if disease states are not taken into account. In this scenario, only intervention on disease states, their risk factors, and other sequelae could, in theory, reduce risk of death. Scenario 3: Low testosterone causes disease states, and sequelae of disease states influence premature death. In this scenario, low testosterone also may influence death without causing disease states, and not all disease states that influence death are caused by low testosterone. In this scenario, prevention or intervention to address low . . . [Full Text of this Article]

issues in using testosterone for predicting premature death in older men
1. what is the optimal definition of low testosterone in older men?
2. what is the optimal assay method for measuring serum testosterone concentration?
3. is total or free testosterone the better predictor of death in older men?
4. what sources of biological variability must be considered?
closing thoughts